Ebstein's anomaly of the tricuspid valve prognosis

Ebsteins anomaly of the tricuspid valve Microchapters
Home
Patient Information
Overview
Historical Perpective
Classification
Pathophysiology
Causes
Differentiating Ebstein's Anomaly from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography
CT
MRI
Other Imaging Findings
Other diagnostic studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Ebstein's anomaly of the tricuspid valve prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ebstein's anomaly of the tricuspid valve prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ebstein's anomaly of the tricuspid valve prognosis
CDC on Ebstein's anomaly of the tricuspid valve prognosis
Ebstein's anomaly of the tricuspid valve prognosis in the news
Blogs on Ebstein's anomaly of the tricuspid valve prognosis
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Ebstein's anomaly of the tricuspid valve prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]

Adverse prognostic factors are

a) NYHA Class III or IV

b) Moderate to severe cardiomegaly

c) Cyanosis or an O2 sat < 90%

d) Disability during infancy

e)Paradoxical emboli